Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of VALESTAR 200 versus Entresto in healthy Thai adults under fasting conditions
TCTR20260808008Phase 1Not yet recruiting
- Sponsor
- T.O. Chemicals
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sacubitril + valsartan, sponsored by T.O. Chemicals. Primary endpoint: Cmax. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
sacubitril + valsartan
Beyond the preview
Go deeper on TCTR20260808008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260808008.